According to Ekso Bionics 's latest financial reports the company's current EPS (TTM) is -$1.12. In 2022 the company made an earnings per share (EPS) of -$1.16 a decrease over its 2021 EPS that were of -$0.82.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.12 | -3.45% |
2022 | -$1.16 | 41.46% |
2021 | -$0.82 | -66.94% |
2020 | -$2.48 | -8.82% |
2019 | -$2.72 | -58.79% |
2018 | -$6.60 | -52.68% |
2017 | -$13.95 | -45.32% |
2016 | -$25.50 | 33.53% |
2015 | -$19.10 | -59.36% |
2014 | -$47.00 | 36194.96% |
2013 | -$0.13 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() STAAR Surgical STAA | $0.42 | -137.50% | ๐บ๐ธ USA |
![]() OraSure Technologies OSUR | $0.58 | -151.79% | ๐บ๐ธ USA |
![]() AtriCure ATRC | -$0.54 | -51.79% | ๐บ๐ธ USA |
![]() Biolase
BIOL | -$264.93 | 23,554.46% | ๐บ๐ธ USA |